Ушбу иш иқтибос қилган ишлар

70 та иш

Иш: SLAMF1 at the crossroads of immunity and disease: Biology, pathology, and therapeutic opportunities

1. SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy

   Pooya Farhangnia, Shamim Mollazadeh Ghomi, Shabnam Mollazadehghomi +3

   Шарҳ мақола20233 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.458827

2. SLAMF receptors negatively regulate B cell receptor signaling in chronic lymphocytic leukemia via recruitment of prohibitin-2

   Lisa von Wenserski, Christoph Schultheiß, Sarah Naomi Bolz +10

   Мақола20202 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.431187

3. SLAMF Receptor Expression Identifies an Immune Signature That Characterizes Systemic Lupus Erythematosus

   Morgane Humbel, Florence Bellanger, Alice Horisberger +8

   Мақола20222 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.431197

4. SAP-Dependent and -Independent Regulation of Innate T Cell Development Involving SLAMF Receptors

   Jaime De Calisto, Ninghai Wang, Guoxing Wang +3

   Мақола20142 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.458798

5. SLAM family receptors in natural killer cells – Mediators of adhesion, activation and inhibition via cis and trans interactions

   Maren Claus, Doris Urlaub, Frank Fasbender +1

   Шарҳ мақола20182 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.458806

6. Comprehensive analysis of signaling lymphocyte activation molecule family as a prognostic biomarker and correlation with immune infiltration in clear cell renal cell carcinoma

   Na Song, Ziwei Wang, Pingyu Shi +7

   Мақола20242 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.458839

7. Homotypic Interactions Mediated by Slamf1 and Slamf6 Receptors Control NKT Cell Lineage Development

   Klaus Griewank, Christine Borowski, Svend T. Rietdijk +6

   Мақола20072 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.778842

8. Negative Regulation of Humoral Immunity Due to Interplay between the SLAMF1, SLAMF5, and SLAMF6 Receptors

   Ninghai Wang, Peter J. Halibozek, Burcu Yigit +5

   Мақола20152 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.778845

9. Identification of CD84 as a potent survival factor in acute myeloid leukemia

   Ying‐Hui Zhu, Mariam Murtadha, Miaomiao Liu +25

   Мақола20252 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.778901

10. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.853195

11. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.853196

12. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.853197

13. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.853198

14. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.853199

15. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.853200

16. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.853201

17. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.853202

18. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.853203

19. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.853204

20. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.853205

21. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.853206

22. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.853207

23. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.853208

24. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.853209

25. Сарлавҳасиз

    Бошқа1 иқтибос

    ABIABI:AkademIndex/openalex/2026.other.853210